C3 and pulmonary fibrosis: Additionally, systemic inflammation caused by COVID-19, such as complement C3 decrease and IL-6, TNF-α increase, are risk factors for long-term lung symptoms and leads to diffuse parenchymal changes in the lungs, including alveolar damage, exudation, and pulmonary fibrosis (36–38).